Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis - PubMed

Affiliations

• PMID: 8312688
• DOI: 10.1007/BF00185607

Comparative Study

Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis

M M Weber et al. Clin Investig. 1993 Nov.

Abstract

The narcotic agent etomidate and the antimycotic drug ketoconazole are known to block steroid biosynthesis in man. To study the different effects of these imidazole derivatives on human adrenal steroid biosynthesis we incubated slices of human adrenal glands with 3H-labeled precursors and increasing concentrations of etomidate or ketoconazole (0-2000 microM). After extraction the labeled metabolites were separated by thin-layer chromatography and quantified by scintillation counting. Etomidate inhibited most potently 11 beta-hydroxylase activity by suppressing the formation of corticosterone from 11-deoxycorticosterone to 1% of control [50% inhibitory concentration (IC50) 0.03 microM] while ketoconazole suppressed 11 beta-hydroxylase to only 39% of control activity (IC50 15 microM). Ketoconazole however, most potently blocked the conversion of 17 alpha-hydroxy-progesterone to androstenedione by C17,20-desmolase to about 15% of control activity (IC50 1 microM) while etomidate showed a much weaker effect on this enzyme with a suppression to 50% of C17,20-desmolase control activity at a concentration of 380 microM. Both imidazole drugs showed a similar strong inhibitory effect on the activity of 17 alpha-hydroxylase (IC50 6-18 microM) and 16 alpha-hydroxylase (IC50 4-8 microM) and did not affect 21-hydroxylase. These in vitro data indicate a predominant inhibitory effect of etomidate on corticosteroid biosynthesis by relative selective inhibition of 11 beta-hydroxylase and of ketoconazole on the adrenal androgen biosynthesis by a predominant inhibition of C17,20-desmolase. This differential inhibitory effect of etomidate and ketoconazole on human steroid biosynthesis may be of clinical importance for a possible therapeutic use of these imidazole derivatives in endocrine disorders.

Similar articles

• The influence of ketoconazole on human adrenal steroidogenesis: incubation studies with tissue slices.

  Engelhardt D, Weber MM, Miksch T, Abedinpour F, Jaspers C. Engelhardt D, et al. Clin Endocrinol (Oxf). 1991 Aug;35(2):163-8. doi: 10.1111/j.1365-2265.1991.tb03516.x. Clin Endocrinol (Oxf). 1991. PMID: 1934533

• Kinetic analysis of inhibition of human adrenal steroidogenesis by ketoconazole.

  Couch RM, Muller J, Perry YS, Winter JS. Couch RM, et al. J Clin Endocrinol Metab. 1987 Sep;65(3):551-4. doi: 10.1210/jcem-65-3-551. J Clin Endocrinol Metab. 1987. PMID: 3497939

• Effect of ketoconazole on human ovarian C17,20-desmolase and aromatase.

  Weber MM, Will A, Adelmann B, Engelhardt D. Weber MM, et al. J Steroid Biochem Mol Biol. 1991 Feb;38(2):213-8. doi: 10.1016/0960-0760(91)90128-r. J Steroid Biochem Mol Biol. 1991. PMID: 2004042

• Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.

  Engelhardt D, Weber MM. Engelhardt D, et al. J Steroid Biochem Mol Biol. 1994 Jun;49(4-6):261-7. doi: 10.1016/0960-0760(94)90267-4. J Steroid Biochem Mol Biol. 1994. PMID: 8043488 Review.

• [Inhibition of steroidogenesis by ketoconazole. Therapeutic uses].

  Miossec P, Archambeaud-Mouveroux F, Teissier MP. Miossec P, et al. Ann Endocrinol (Paris). 1997;58(6):494-502. Ann Endocrinol (Paris). 1997. PMID: 9686009 Review. French.

Cited by

• Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies.

  Lerario AM, Mohan DR, Hammer GD. Lerario AM, et al. Endocr Rev. 2022 Nov 25;43(6):1051-1073. doi: 10.1210/endrev/bnac012. Endocr Rev. 2022. PMID: 35551369 Free PMC article.

• 11β-Hydroxylase inhibitors protect against seizures in mice by increasing endogenous neurosteroid synthesis.

  Kaminski RM, Rogawski MA. Kaminski RM, et al. Neuropharmacology. 2011 Jul-Aug;61(1-2):133-7. doi: 10.1016/j.neuropharm.2011.03.019. Epub 2011 Mar 31. Neuropharmacology. 2011. PMID: 21458468 Free PMC article.

• Comparative tolerability of sedative agents in head-injured adults.

  Urwin SC, Menon DK. Urwin SC, et al. Drug Saf. 2004;27(2):107-33. doi: 10.2165/00002018-200427020-00003. Drug Saf. 2004. PMID: 14717622 Review.

• Adrenal Incidentaloma.

  Sherlock M, Scarsbrook A, Abbas A, Fraser S, Limumpornpetch P, Dineen R, Stewart PM. Sherlock M, et al. Endocr Rev. 2020 Dec 1;41(6):775-820. doi: 10.1210/endrev/bnaa008. Endocr Rev. 2020. PMID: 32266384 Free PMC article. Review.

• Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma.

  Michalski K, Schlötelburg W, Hartrampf PE, Kosmala A, Buck AK, Hahner S, Schirbel A. Michalski K, et al. Pharmaceuticals (Basel). 2023 Dec 23;17(1):25. doi: 10.3390/ph17010025. Pharmaceuticals (Basel). 2023. PMID: 38256859 Free PMC article. Review.

References

Publication types

MeSH terms

Substances